RNU1-61P

Across TCGA pan-cancer cohorts, RNU1-61P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RNU1-61P data layer compared with 17 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNU1-61P Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU1-61P expression acts as an unfavorable survival marker.

LUAD are the cancer types where RNU1-61P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.098	0.791	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

RNU1-61P–LUAD (DFS)

Open the LUAD breakdown →